262 related articles for article (PubMed ID: 17606903)
1. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4.
Bah A; Chen Z; Bush-Pelc LA; Mathews FS; Di Cera E
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11603-8. PubMed ID: 17606903
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
Jacques SL; Kuliopulos A
Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
[TBL] [Abstract][Full Text] [Related]
3. Molecular mapping of thrombin-receptor interactions.
Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E
Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface.
Cleary DB; Trumbo TA; Maurer MC
Arch Biochem Biophys; 2002 Jul; 403(2):179-88. PubMed ID: 12139967
[TBL] [Abstract][Full Text] [Related]
5. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
Arachiche A; de la Fuente M; Nieman MT
PLoS One; 2013; 8(2):e55740. PubMed ID: 23405206
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of thrombin-protease-activated receptor interactions.
Gandhi PS; Chen Z; Appelbaum E; Zapata F; Di Cera E
IUBMB Life; 2011 Jun; 63(6):375-82. PubMed ID: 21698746
[TBL] [Abstract][Full Text] [Related]
7. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
[TBL] [Abstract][Full Text] [Related]
10. Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.
Nieman MT; Schmaier AH
Biochemistry; 2007 Jul; 46(29):8603-10. PubMed ID: 17595115
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
13. A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets.
Sánchez Centellas D; Gudlur S; Vicente-Carrillo A; Ramström S; Lindahl TL
Thromb Res; 2017 Jun; 154():84-92. PubMed ID: 28448853
[TBL] [Abstract][Full Text] [Related]
14. PAR3 is a cofactor for PAR4 activation by thrombin.
Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
Nieman MT
Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
[TBL] [Abstract][Full Text] [Related]
16. Trypsin causes platelet activation independently of known protease-activated receptors.
Mao Y; Kunapuli SP
Thromb Haemost; 2013 Dec; 110(6):1241-9. PubMed ID: 24030758
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced platelet activation via PAR4: pivotal role for exosite II.
Boknäs N; Faxälv L; Sanchez Centellas D; Wallstedt M; Ramström S; Grenegård M; Lindahl TL
Thromb Haemost; 2014 Sep; 112(3):558-65. PubMed ID: 24990072
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
20. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
Altrogge LM; Monard D
Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
